DUBLIN–(BUSINESS WIRE)–The “Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) – Global Forecast 2022” report has been added to ResearchAndMarkets.com’s offering.
The Global Transradial Access Devices Market is Expected to Grow at a CAGR of 7.5% to Reach to USD 2.18 Billion By 2022 from an Estimated USD 1.52 Billion in 2017.
The driving factors of this market are rising prevalence of obesity, increasing preference for interventional procedures using radial artery access, growing utilization of radial access devices in treating pediatric patients, and prevalence of lifestyle diseases.
By product, the transradial access devices market is segmented into catheters, guidewires, sheaths and sheath introducers, and accessories (needles and cannulas). Catheters accounted for the largest share of the transradial access devices market in 2017 and this segment is also expected to grow at the highest rate during the forecast period. Factors driving the growth of this segment are the increasing incidence of lifestyle-related diseases such as CVD, obesity, and diabetes and the rising number of interventional and angiography procedures worldwide.
Transradial access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. Of all these application segments, the drug administration segment commanded the largest share of the transradial access devices market in 2017.
The large share of this segment can be attributed to the high usage of vascular access devices for drug administration, predominantly for the treatment of cancer and infections.
On the basis of end users the transradial access devices market is categorized into hospitals, clinics and ambulatory care centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment is expected to grow at the highest CAGR during the forecast period.
Transradial access devices market is divided into four major regions North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to register the highest CAGR during the forecast period. The key driving factors for the growth of this regional segment are the growing prevalence of CVDs, increasing number of cancer patients and, increase in research and clinical trials for vascular access devices.
Becton, Dickinson and Company (US) and Terumo Corporation (Japan) dominated the transradial access devices market in 2017.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Transradial Access Devices Market, By Product
7 Transradial Access Devices Market, By Application
8 Transradial Access Devices Market, By End User
9 Transradial Access Devices Market, By Region
10 Competitive Landscape
11 Company Profiles
- Ameco Medical
- Angiodynamics, Inc.
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Edward Lifesciences Corporation
- Medtronic
- Merit Medical Systems
- Nipro Medical Corporation
- Oscor Inc.
- Smiths Medical
- Teleflex Incorporated
- Terumo Corporation
For more information about this report visit https://www.researchandmarkets.com/research/xdgcb7/transradial?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices
